Ashlee Newland
Physician Assistant · Kingsport, TNNPI 1295059590
Payments from drug & device makers
Across 340 payments — averaging $17.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Amgen$671
- Sun Pharmaceutical Industries Inc.$480
- E.r. Squibb & Sons, L.L.C.$471
- Johnson & Johnson$406
- Novartis$382
- plus $2K from 22 others
What the payments were for
- Food & beverage$5,78496%
- Education$2334%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 82 | $1,358 |
| Amgen(2 entities) | 39 | $671 |
| Sun Pharmaceutical Industries Inc. | 27 | $480 |
| E.r. Squibb & Sons, L.L.C. | 27 | $471 |
| Johnson & Johnson | 24 | $406 |
| Novartis | 20 | $382 |
| UCB, Inc. | 21 | $358 |
| Pfizer | 22 | $328 |
| Lilly USA, LLC | 18 | $280 |
| Incyte Corporation | 8 | $226 |
| Regeneron Healthcare Solutions, Inc. | 8 | $216 |
| Actelion Pharmaceuticals US, Inc. | 7 | $126 |
| Mallinckrodt Hospital Products Inc. | 6 | $111 |
| Sanofi | 3 | $75 |
| GSK | 5 | $73 |
| Aurinia Pharma U.S., Inc. | 3 | $59 |
| Organogenesis Inc. | 2 | $55 |
| Merck | 2 | $53 |
| Boehringer Ingelheim | 2 | $51 |
| Mayne Pharma Commercial LLC | 2 | $47 |
| Radius Health, Inc. | 3 | $47 |
| Galderma Laboratories, L.p. | 2 | $40 |
| Genentech USA, Inc. | 2 | $21 |
| Janssen Scientific Affairs, LLC | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Biofrontera Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| AstraZeneca | 1 | $11 |
How this compares
$6,017 in reported general payments places this provider in the 90th percentile of 2,404 physician assistant providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OtezlaApremilast | 13 | $61,571 |
| Fluorouracil | 48 | $4,255 |
| Clobetasol Propionate | 61 | $2,929 |
| Metronidazole | 27 | $1,237 |
| Selenium Sulfide | 78 | $741 |
| Nystatin | 41 | $632 |
| Ketoconazole | 24 | $628 |
| Betamethasone Dipropionate | 14 | $466 |
| Ciclopirox | 16 | $278 |
| Doxycycline Hyclate | 18 | $183 |
| Triamcinolone Acetonide | 24 | $159 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenOtezla | $671 | $61,57113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,404 physician assistant providers in Tennessee.
Other physician assistant in Kingsport
- Sandra McCraryKingsport$17K
- Philip WeatherfordKingsport$16K
- William JohnsonKingsport$13K
- Harold LittleKingsport$13K
- Rachel RiceKingsport$11K
- Lindsey NixKnoxville$576K
- Anna KerseySavannah$399K
- Jason HenryNashville$329K
- Brie ChandlerNashville$317K
- Loree EasleyBartlett$209K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.